Arvelle Therapeutics

Arvelle Therapeutics

A biopharmaceutical company with the mission of bringing innovative solutions to patients suffering from CNS disorders.
Zug Switzerland (HQ), Basel Switzerland

Arvelle Therapeutics Company information

Edit
Launch date
Employees
59 people
Ownership
Firm valuation
€155—233m (Dealroom.co estimates May 2020.)
  • Edit

Recent News about Arvelle Therapeutics

Edit
Lists
LocationEdit
Zählerweg 6, 6300 Zug, Switzerland
Are you an employee or an investor of this company?
Add your profile